Literature DB >> 22843445

Transforming growth factor-β: transforming plaque to stability.

Kevin Tse1, Klaus Ley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843445      PMCID: PMC3869967          DOI: 10.1093/eurheartj/ehs228

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  16 in total

1.  Flt3 signaling-dependent dendritic cells protect against atherosclerosis.

Authors:  Jae-Hoon Choi; Cheolho Cheong; Durga B Dandamudi; Chae Gyu Park; Anthony Rodriguez; Saurabh Mehandru; Klara Velinzon; In-Hyuk Jung; Ji-Young Yoo; Goo Taeg Oh; Ralph M Steinman
Journal:  Immunity       Date:  2011-11-10       Impact factor: 31.745

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.

Authors:  Dirk Lievens; Kim L Habets; Anna-Karin Robertson; Yasmina Laouar; Holger Winkels; Timo Rademakers; Linda Beckers; Erwin Wijnands; Louis Boon; Munir Mosaheb; Hafid Ait-Oufella; Ziad Mallat; Richard A Flavell; Mats Rudling; Christoph J Binder; Norbert Gerdes; Erik A L Biessen; Christian Weber; Mat J A P Daemen; Johan Kuiper; Esther Lutgens
Journal:  Eur Heart J       Date:  2012-05-21       Impact factor: 29.983

4.  Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.

Authors:  Sergio Stefoni; Giuseppe Cianciolo; Gabriele Donati; Ada Dormi; Maria Grazia Silvestri; Luigi Colì; Antonio De Pascalis; Sandra Iannelli
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

5.  Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

Authors:  Z Mallat; A Gojova; C Marchiol-Fournigault; B Esposito; C Kamaté; R Merval; D Fradelizi; A Tedgui
Journal:  Circ Res       Date:  2001-11-09       Impact factor: 17.367

6.  Growth factor expression in aorta of normotensive and hypertensive rats.

Authors:  R Sarzani; P Brecher; A V Chobanian
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.

Authors:  Anna-Karin L Robertson; Mats Rudling; Xinghua Zhou; Leonid Gorelik; Richard A Flavell; Göran K Hansson
Journal:  J Clin Invest       Date:  2003-10-20       Impact factor: 14.808

8.  Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease.

Authors:  Hideki Tashiro; Hiroaki Shimokawa; Kenji Sadamatu; Kunihiko Yamamoto
Journal:  Coron Artery Dis       Date:  2002-05       Impact factor: 1.439

9.  Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice.

Authors:  Andrea Gojova; Valérie Brun; Bruno Esposito; Françoise Cottrez; Pierre Gourdy; Patrice Ardouin; Alain Tedgui; Ziad Mallat; Hervé Groux
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

10.  Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.

Authors:  Esther Lutgens; Marion Gijbels; Marjan Smook; Peter Heeringa; Philip Gotwals; Victor E Koteliansky; Mat J A P Daemen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  4 in total

Review 1.  T cells in atherosclerosis.

Authors:  Kevin Tse; Harley Tse; John Sidney; Alex Sette; Klaus Ley
Journal:  Int Immunol       Date:  2013-11       Impact factor: 4.823

2.  Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution.

Authors:  Patrick B Ampomah; Bishuang Cai; Santosh R Sukka; Brennan D Gerlach; Arif Yurdagul; Xiaobo Wang; George Kuriakose; Lancia N F Darville; Yan Sun; Simone Sidoli; John M Koomen; Alan R Tall; Ira Tabas
Journal:  Nat Metab       Date:  2022-03-31

3.  Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

Authors:  Kevin Tse; Ayelet Gonen; John Sidney; Hui Ouyang; Joseph L Witztum; Alessandro Sette; Harley Tse; Klaus Ley
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

4.  Galectin-3 Identifies a Subset of Macrophages With a Potential Beneficial Role in Atherosclerosis.

Authors:  Karina Di Gregoli; Michelle Somerville; Rosaria Bianco; Anita C Thomas; Aleksandra Frankow; Andrew C Newby; Sarah J George; Christopher L Jackson; Jason L Johnson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-16       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.